- Home
- ACET vs STI Comparison
ACET vs STI Comparison
Compare ACET & STI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- STI
- Stock Information
- Founded
- ACET 1947
- STI 2014
- Country
- ACET United States
- STI United States
- Employees
- ACET N/A
- STI N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- STI
- Sector
- ACET Health Care
- STI
- Exchange
- ACET Nasdaq
- STI NYSE
- Market Cap
- ACET 44.4M
- STI 51.2M
- IPO Year
- ACET N/A
- STI N/A
- Fundamental
- Price
- ACET $0.59
- STI $0.11
- Analyst Decision
- ACET Buy
- STI
- Analyst Count
- ACET 6
- STI 0
- Target Price
- ACET $6.00
- STI N/A
- AVG Volume (30 Days)
- ACET 509.0K
- STI 4.1M
- Earning Date
- ACET 05-13-2025
- STI 06-06-2025
- Dividend Yield
- ACET N/A
- STI N/A
- EPS Growth
- ACET N/A
- STI N/A
- EPS
- ACET N/A
- STI N/A
- Revenue
- ACET N/A
- STI N/A
- Revenue This Year
- ACET N/A
- STI N/A
- Revenue Next Year
- ACET N/A
- STI N/A
- P/E Ratio
- ACET N/A
- STI N/A
- Revenue Growth
- ACET N/A
- STI N/A
- 52 Week Low
- ACET $0.45
- STI $0.08
- 52 Week High
- ACET $1.87
- STI $3.25
- Technical
- Relative Strength Index (RSI)
- ACET 42.27
- STI 43.69
- Support Level
- ACET $0.51
- STI $0.09
- Resistance Level
- ACET $0.62
- STI $0.12
- Average True Range (ATR)
- ACET 0.06
- STI 0.02
- MACD
- ACET 0.01
- STI 0.01
- Stochastic Oscillator
- ACET 63.38
- STI 38.04
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About STI SOLIDION TECHNOLOGY INC
Solidion Technology Inc is engaged in researching, developing and manufacturing battery materials and components, as well as the development and production of next-generation batteries for energy storage systems and electric vehicles for ground, air, and sea transportation. It is recognized as a global IP leader in both the high-capacity anode and the high-energy solid-state battery.